{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:59:18Z","timestamp":1792144758142,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cardfail.2025.11.488","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T07:53:30Z","timestamp":1764143610000},"page":"1224-1233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Nir","family":"Uriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Netuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich P.","family":"Jorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis D.","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zimpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriy","family":"Pya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriram","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mara","family":"Scandroglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Dirckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-7044","authenticated-orcid":false,"given":"Mandeep R.","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2025.11.488_bib0001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0002","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ejhf.1818","article-title":"Trends in prevalence of comorbidities in heart failure clinical trials","volume":"22","author":"Khan","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0003","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/europace\/euac130","article-title":"The association of coagulation and atrial fibrillation: a systematic review and meta-analysis","volume":"25","author":"Tilly","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcvm.2018.00001","article-title":"Thrombosis and vascular inflammation in diabetes: mechanisms and potential therapeutic targets","volume":"5","author":"Pechlivani","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/ejh.13560","article-title":"The hematologic consequences of obesity","volume":"106","author":"Purdy","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.12210","article-title":"Use of preventive aspirin among older US adults with and without diabetes","volume":"4","author":"Liu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100256","article-title":"Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use","volume":"8","author":"Boakye","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0008","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.jacc.2016.03.581","article-title":"Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke","volume":"67","author":"Hsu","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0009","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/eurheartj\/ehad658","article-title":"Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry","volume":"45","author":"Schmitto","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0011","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.athoracsur.2023.11.004","article-title":"The Society of Thoracic Surgeons Intermacs 2023 Annual Report: focus on magnetically levitated devices","volume":"117","author":"Jorde","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0012","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.healun.2019.05.006","article-title":"Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: a prospective multicenter clinical trial","volume":"38","author":"Bansal","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0013","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.jacc.2009.02.048","article-title":"Severely impaired von willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II)","volume":"53","author":"Klovaite","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0014","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.2023.23204","article-title":"Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: The ARIES-HM3 randomized clinical trial","volume":"330","author":"Mehra","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamacardio.2024.4849","article-title":"Aspirin and hemocompatibility after LVAD implantation in patients with atherosclerotic vascular disease: a secondary analysis from the ARIES-HM3 randomized clinical trial","volume":"10","author":"Gustafsson","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0016","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ejhf.2275","article-title":"Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-007-0898-3","article-title":"Aspirin resistance and diabetes mellitus","volume":"51","author":"Ajjan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0018","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/jth.14445","article-title":"Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation","volume":"17","author":"Petrucci","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0019","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jacc.2016.11.049","article-title":"Type 2 diabetes, obesity, and aspirin responsiveness","volume":"69","author":"Patrono","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0020","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.healun.2023.06.003","article-title":"The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS \u2013 OPTN\/UNOS data analysis","volume":"42","author":"Alba","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.healun.2024.09.031","article-title":"Early stroke following durable left ventricular assist device (LVAD) implantation: an analysis of the Society of Thoracic Surgeons Intermacs National Database","volume":"44","author":"Molina","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008360","article-title":"Impact of race on clinical outcomes after implantation with a fully magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 trial","volume":"14","author":"Sheikh","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0023","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks","volume":"18","author":"Aguilar","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.cardfail.2025.11.488_bib0024","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","article-title":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease","volume":"4","author":"Capodanno","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40262-017-0611-8","article-title":"Obesity and altered aspirin pharmacology","volume":"57","author":"Norgard","year":"2018","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.1016\/j.cardfail.2025.11.488_bib0026","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0027","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.2022.5207","article-title":"Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement","volume":"327","author":"Davidson","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2025.11.488_bib0028","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425010292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425010292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:26:22Z","timestamp":1784017582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425010292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1071916425010292"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.11.488","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Atrial Fibrillation, Diabetes Mellitus, and Obesity on Outcomes With Aspirin Avoidance and Hemocompatibility With a Left Ventricular Assist Device: An Analysis From the ARIES-HM3 Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.11.488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}